@article{1484360,
      author = {Yap, Timothy A., and Shapiro, Geoffrey I.},
      url = {http://library.usi.edu/record/1484360},
      title = {Targeting the DNA damage response for cancer therapy /},
      abstract = {This book discusses the latest developments in Poly  (ADP-ribose) polymerase (PARP) inhibitor drug development.  It focuses on the translational and clinical development of  the latest drugs, as well as the evidence for regulatory  approval of PARP inhibitors in multiple different molecular  subtypes and tumor indications. The most-up-to-date  information on basic scientific research on DNA repair  pathways and the DNA Damage Response (DDR) is also covered.  Every chapter contains insight into the preclinical,  translational along with clinical aspects of a specific DDR  inhibitor with key and expert opinion points reinforcing  the most important concepts detailed to enable the reader  to develop a deep understanding of the topic. Targeting the  DNA Damage Response for Cancer Therapy comprehensively  reviews the application of PARP and other DDR inhibitors  across oncology disciplines. Therefore, it is a valuable  resource for all medical professionals and researchers who  use or who are researching the use of these inhibitors on a  day-to-day basis.},
      doi = {https://doi.org/10.1007/978-3-031-30065-3},
      recid = {1484360},
      pages = {1 online resource (420 pages) :},
}